A chewable tablet formulation of Vyvanse (lisdexamfetamine dimesylate) is available, offering an alternative dosage form for the medication used to treat attention-deficit/hyperactivity disorder (ADHD) [1]. This chewable form dissolves in the mouth, potentially providing a different administration experience compared to capsules [1].
Can Vyvanse chewables be taken by adults?
Yes, the chewable tablet formulation of Vyvanse is indicated for use in adults with ADHD [1].
How is the Vyvanse chewable tablet different from the capsule?
The primary difference lies in the dosage form and administration. The chewable tablet is designed to be chewed and dissolved in the mouth, whereas the original Vyvanse is a capsule that contains beads which are typically swallowed whole or opened and mixed with yogurt or water [1]. The active ingredient, lisdexamfetamine dimesylate, and its therapeutic effect remain the same across different formulations [1].
When does the patent for Vyvanse expire?
The patent situation for Vyvanse is complex, with multiple patents covering the drug. DrugPatentWatch.com indicates that key patents related to lisdexamfetamine dimesylate have expiration dates that have passed or are approaching. For example, patents related to the formulation and method of use have seen challenges and expirations [2]. Specific patent expiry dates can vary due to litigation and regulatory exclusivities.
What are the risks and side effects associated with Vyvanse chewables?
Vyvanse chewables carry the same potential risks and side effects as other lisdexamfetamine formulations. Common side effects include decreased appetite, dry mouth, difficulty sleeping, weight loss, and anxiety [1]. More serious risks may include cardiovascular problems, psychiatric disorders, and potential for abuse or dependence [1]. Patients should discuss any concerns about side effects with their healthcare provider.
Are there generic versions of Vyvanse chewables available?
As of late 2023, generic versions of lisdexamfetamine dimesylate capsules are available. The availability of generic chewable tablet formulations would typically follow the patent expiry and regulatory approval processes [2].
How does Vyvanse compare to other ADHD medications?
Vyvanse is a stimulant medication. Its mechanism of action involves increasing levels of dopamine and norepinephrine in the brain, which can help improve focus and attention. Other ADHD medications include other stimulants like methylphenidate (e.g., Ritalin, Concerta) and non-stimulant medications such as atomoxetine (Strattera) or guanfacine (Intuniv) [1]. The choice of medication depends on individual patient needs, response, and tolerability.
What should I consider before switching to Vyvanse chewables?
Considerations for switching to Vyvanse chewables include personal preference for medication form, ease of administration, and any specific recommendations from a healthcare provider. The effectiveness and side effect profile are generally consistent with other Vyvanse formulations [1].
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022278s032,209849s009,217239s004lbl.pdf
[2] https://drugpatentwatch.com/